Siegfried Opens New Drug Substances R&D Center in Evionnaz Zofingen, Switzerland-based contract development and manufacturing organization (#CDMO) Siegfried inaugurated its new global research and development (R&D) center for drug substances at its site in Evionnaz, #Switzerland. The 4,500 m2 center houses chemical and analytical facilities, laboratories, and technologies such as flow #chemistry, advanced #distillation and process analytical technology, as well as new office space. Together with the R&D center in Zofingen, it will offer chemical process R&D and analytical development services for Siegfried's global drug substances network. With workspaces for over 100 specialists and 40 new jobs created, the R&D center strengthens Siegfried’s development capabilities in phase II and III supporting the company's Evolve+ strategy, the company said. Read more on #CMI online:
